{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T13:05:33Z","timestamp":1782824733694,"version":"3.54.5"},"reference-count":32,"publisher":"Stanford University Press","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Mass Spectrometry"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.clinms.2018.08.004","type":"journal-article","created":{"date-parts":[[2018,8,17]],"date-time":"2018-08-17T13:40:56Z","timestamp":1534513256000},"page":"25-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Urine analysis of 28 designer benzodiazepines by liquid chromatography\u2013high-resolution mass spectrometry"],"prefix":"10.21627","volume":"10","author":[{"given":"Madeleine","family":"Pettersson Bergstrand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olof","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7480-8078","authenticated-orcid":false,"given":"Anders","family":"Helander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4811","reference":[{"key":"10.1016\/j.clinms.2018.08.004_b0005","unstructured":"European Monitoring Centre for Drugs and Drug Addication: European Drug Report 2017, http:\/\/www.emcdda.europa.eu\/system\/files\/publications\/4541\/TDAT17001ENN.pdf (accessed 02.27.18)."},{"key":"10.1016\/j.clinms.2018.08.004_b0010","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3109\/00365513.2013.793817","article-title":"Identification of novel psychoactive drug use in Sweden based on laboratory analysis-initial experiences from the STRIDA project","volume":"73","author":"Helander","year":"2013","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.clinms.2018.08.004_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15563650.2016.1217003","article-title":"New Psychoactive Substances (NPS) \u2013 the Hydra monster of recreational drugs","volume":"55","author":"Helander","year":"2017","journal-title":"Clin. Toxicol. (Phila)"},{"key":"10.1016\/j.clinms.2018.08.004_b0020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.aca.2016.04.046","article-title":"Review: LC coupled to low- and high-resolution mass spectrometry for new psychoactive substance screening in biological matrices \u2013 where do we stand today?","volume":"927","author":"Meyer","year":"2016","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.clinms.2018.08.004_b0025","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1177\/0269881113503509","article-title":"Benzodiazepines: risks and benefits A reconsideration","volume":"27","author":"Baldwin","year":"2013","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.clinms.2018.08.004_b0030","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11419-013-0187-4","article-title":"Characterization of the designer benzodiazepine pyrazolam and its detectability in human serum and urine","volume":"31","author":"Moosmann","year":"2013","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.clinms.2018.08.004_b0035","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/jms.3279","article-title":"Detection and identification of the designer benzodiazepine flubromazepam and preliminary data on its metabolism and pharmacokinetics","volume":"48","author":"Moosmann","year":"2013","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.clinms.2018.08.004_b0040","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/dta.1628","article-title":"Characterization of the designer benzodiazepine diclazepam and preliminary data on its metabolism and pharmacokinetics","volume":"6","author":"Moosmann","year":"2014","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.clinms.2018.08.004_b0045","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s11419-015-0277-6","article-title":"Characterization of the four designer benzodiazepines clonazolam, deschloroetizolam, flubromazolam, and meclonazepam, and identification of their in vitro metabolites","volume":"33","author":"Huppertz","year":"2015","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.clinms.2018.08.004_b0050","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/jms.3840","article-title":"Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines \u2013 an update comprising adinazolam, cloniprazepam, fonazepam, 3-hydroxyphenazepam, metizolam and nitrazolam","volume":"51","author":"Moosmann","year":"2016","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.clinms.2018.08.004_b0055","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/dta.2211","article-title":"The emergence of new psychoactive substance (NPS) benzodiazepines: a review","volume":"10","author":"Manchester","year":"2018","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.clinms.2018.08.004_b0060","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/dta.2003","article-title":"Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays","volume":"9","author":"Pettersson Bergstrand","year":"2017","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.clinms.2018.08.004_b0065","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/jat\/bkv122","article-title":"ELISA detection of phenazepam, etizolam, pyrazolam, flubromazepam, diclazepam and delorazepam in blood using immunalysis(R) Benzodiazepine kit","volume":"40","author":"O'Connor","year":"2016","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.clinms.2018.08.004_b0070","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1002\/jssc.201700069","article-title":"Analysis of selected designer benzodiazepines by ultra high performance liquid chromatography with high-resolution time-of-flight mass spectrometry and the estimation of their partition coefficients by micellar electrokinetic chromatography","volume":"40","author":"Tomkova","year":"2017","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.clinms.2018.08.004_b0075","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.talanta.2017.08.010","article-title":"Simultaneous determination of designer benzodiazepines in human serum using non-aqueous capillary electrophoresis \u2013 tandem mass spectrometry with successive multiple ionic \u2013 polymer layer coated capillary","volume":"176","author":"Svidrnoch","year":"2018","journal-title":"Talanta"},{"key":"10.1016\/j.clinms.2018.08.004_b0080","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jchromb.2017.04.008","article-title":"Ultrasound-assisted low-density solvent dispersive liquid-liquid microextraction for the determination of 4 designer benzodiazepines in urine samples by gas chromatography-triple quadrupole mass spectrometry","volume":"1053","author":"Meng","year":"2017","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.clinms.2018.08.004_b0085","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jchromb.2016.08.047","article-title":"Development and application of a multi-component LC-MS\/MS method for determination of designer benzodiazepines in urine","volume":"1035","author":"Pettersson Bergstrand","year":"2016","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.clinms.2018.08.004_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11419-016-0338-5","article-title":"Metabolites replace the parent drug in the drug arena. The cases of fonazepam and nifoxipam","volume":"35","author":"Katselou","year":"2017","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.clinms.2018.08.004_b0095","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/jms.3946","article-title":"Use of LC-HRMS in full scan-XIC mode for multi-analyte urine drug testing \u2013 a step towards a \u2018black-box\u2019 solution?","volume":"52","author":"Stephanson","year":"2017","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.clinms.2018.08.004_b0100","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jflm.2011.12.014","article-title":"Phenazepam: the drug that came in from the cold","volume":"19","author":"Maskell","year":"2012","journal-title":"J. Forensic Leg. Med."},{"key":"10.1016\/j.clinms.2018.08.004_b0105","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2174\/138920008786049258","article-title":"Benzodiazepine metabolism: an analytical perspective","volume":"9","author":"Mandrioli","year":"2008","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.clinms.2018.08.004_b0110","doi-asserted-by":"crossref","first-page":"6516","DOI":"10.4081\/pr.2016.6516","article-title":"Clobazam and its use in epilepsy","volume":"8","author":"Pernea","year":"2016","journal-title":"Pediatr. Rep."},{"key":"10.1016\/j.clinms.2018.08.004_b0115","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1016\/j.clinthera.2016.09.010","article-title":"Review of safety and efficacy of sleep medicines in older adults","volume":"38","author":"Schroeck","year":"2016","journal-title":"Clin. Ther."},{"key":"10.1016\/j.clinms.2018.08.004_b0120","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/03602532.2017.1377223","article-title":"Metabolic profile of oxazepam and related benzodiazepines: clinical and forensic aspects","volume":"49","author":"Dinis-Oliveira","year":"2017","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.clinms.2018.08.004_b0125","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1021\/ci500503b","article-title":"Discovery of FDA-approved drugs as inhibitors of fatty acid binding protein 4 using molecular docking screening","volume":"54","author":"Wang","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.clinms.2018.08.004_b0130","first-page":"705","article-title":"On the clinical evidence leading to tetrazepam withdrawal","volume":"13","author":"Proy-Vega","year":"2014","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.clinms.2018.08.004_b0135","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jchromb.2004.04.039","article-title":"Confirmatory analysis for drugs of abuse in plasma and urine by high-performance liquid chromatography-tandem mass spectrometry with respect to criteria for compound identification","volume":"811","author":"Maralikova","year":"2004","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.clinms.2018.08.004_b0140","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal. Chem."},{"key":"10.1016\/j.clinms.2018.08.004_b0145","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/jat\/bkx031","article-title":"Reports of adverse events associated with use of novel psychoactive substances, 2013\u20132016: a review","volume":"41","author":"Logan","year":"2017","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.clinms.2018.08.004_b0150","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0379-0738(92)90081-7","article-title":"Quantitative liquid chromatography, thermospray\/tandem mass spectrometry (LC\/TSP\/MS\/MS) analysis of some thermolabile benzodiazepines in whole-blood","volume":"54","author":"Verweij","year":"1992","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.clinms.2018.08.004_b0155","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/jat\/bkr008","article-title":"Benzodiazepine stability in postmortem samples stored at different temperatures","volume":"36","author":"Melo","year":"2012","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.clinms.2018.08.004_b0160","unstructured":"Svensk f\u00f6rfattningssamling: F\u00f6rordning om \u00e4ndring i f\u00f6rordningen (1992:1554) om kontroll av narkotika; SFS 2016:1303, https:\/\/www.notisum.se\/rnp\/sls\/sfs\/20161303.pdf (accessed 01.01.18.)."}],"container-title":["Clinical Mass Spectrometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2376999818300126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2376999818300126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T03:47:33Z","timestamp":1770263253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2376999818300126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":32,"alternative-id":["S2376999818300126"],"URL":"https:\/\/doi.org\/10.1016\/j.clinms.2018.08.004","relation":{},"ISSN":["2376-9998"],"issn-type":[{"value":"2376-9998","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urine analysis of 28 designer benzodiazepines by liquid chromatography\u2013high-resolution mass spectrometry","name":"articletitle","label":"Article Title"},{"value":"Clinical Mass Spectrometry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinms.2018.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Association for Mass Spectrometry: Applications to the Clinical Lab (MSACL). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}